Neurogenic Bladder

  • Chapter
  • First Online:
Principles and Practice of Urogynaecology

Abstract

The term “neurogenic bladder” encompasses a variety of clinical and urodynamic entities. In general, it refers to clinical problems related to bladder dysfunction secondary to underlying neurological conditions. It is important to obtain a thorough clinical history followed by examination including a good neurological assessment. While this may give clues to the underlying problem, correct management will not be achieved without the aid of laboratory testing, imaging, and urodynamic evaluation, the last in many patients playing a key role in their management. While certain conditions may warrant specific treatments, management, in general, becomes easy once patients are classified based on their urodynamic pattern. The key determinant in the management of neuro-urological problems is to ascertain whether the bladder is “safe” or “unsafe,” i.e., its impact on the renal function. Once this has been determined, management of these entities becomes easy. It is worth remembering that the bladder is a dynamic organ and tends to change physiologically and hence functionally over time. In this chapter, key concepts in identification and management of common clinical entities that cause “neurogenic bladder” will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 53.49
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 69.54
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 96.29
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Rortveit G, Hannestad YS, Daltveit AK, Hunskaar S. Age- and type-dependent effects of parity on urinary incontinence: the Norwegian EPINCONT study. Obstet Gynecol. 2001;98:1004–10.

    Article  CAS  PubMed  Google Scholar 

  2. Madersbacher H. The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts. Paraplegia. 1990;28:217–29.

    Article  CAS  PubMed  Google Scholar 

  3. Haylen B, Ridder D, Freeman R, Steven S, Berghmans B, et al. An International Urogynaecological Association (IUGA), International Continence Society (ICS) joint report on the terminology of pelvic floor dysfunction. NeurourolUrodyn. 2010;29:4–20.

    Google Scholar 

  4. Furlan JC. Autonomic dysreflexia: a clinical emergency. JTrauma Acute Care Surg. 2013;75:496–500.

    Article  Google Scholar 

  5. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol. 1981;126:205–9.

    CAS  PubMed  Google Scholar 

  6. McGuire EJ, Fitzpatrick CC, Wan J, Bloom D, Sanvordenker J, Ritchey M, Gormley EA. Clinical assessment of urethral sphincter function. J Urol. 1993;150:1452–4.

    CAS  PubMed  Google Scholar 

  7. Madersbacher H, Mürtz G, Stöhrer M. Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics. Spinal Cord. 2013;51:432–41.

    Article  CAS  PubMed  Google Scholar 

  8. Radomski S, Jayarajan J. Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life. Res Rep Urol. 2014;6:1–16.

    PubMed Central  Google Scholar 

  9. Kakizaki H, Ameda K, Kobayashi S, Tanaka H, Shibata T, Koyanagi T. Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder. Int J Urol. 2003;10(11):576–81.

    Article  CAS  PubMed  Google Scholar 

  10. Cameron A, Clemens J, Latini J, McGuire E. Combination drug therapy improves compliance of the neurogenic bladder. J Urol. 2009;182:1062–7.

    Article  PubMed  Google Scholar 

  11. Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164:692–7.

    Article  CAS  PubMed  Google Scholar 

  12. Mangera A, Andersson K-EE, Apostolidis A, Chapple C, Dasgupta P, Giannantoni A, Gravas S, Madersbacher S. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol. 2011;60:784–95.

    Article  CAS  PubMed  Google Scholar 

  13. Phelan MW, Franks M, Somogyi GT, Yokoyama T, Fraser MO, Lavelle JP, Yoshimura N, Chancellor MB. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol. 2001;165(4):1107–10.

    Article  CAS  PubMed  Google Scholar 

  14. Chartier-Kastler E, Denys P. Intermittent catheterization with hydrophilic catheters as a treatment of chronic neurogenic urinary retention. NeurourolUrodyn. 2011;30:21–31.

    Google Scholar 

  15. Wein AJ. Lower urinary tract dysfunction in neurologic injury and disease. In: Wein AJ et al., editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007.

    Google Scholar 

  16. Osman N, Chapple C. Fowler’s syndrome – a cause of unexplained urinary retention in young women? Nat Rev Urol. 2014;11:87–98.

    Article  PubMed  Google Scholar 

  17. Seth JH, Sahai A, Khan MS, Van der AF, de Ridder D, Panicker JN, Dasgupta P, Fowler CJ. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? BJU Int. 2013;111:372–80.

    Article  CAS  PubMed  Google Scholar 

  18. Peters K, Gilmer H, Feber K, Girdler B, Nantau W, Trock G, Killinger K, Boura J. US pilot study of lumbar to sacral nerve rerouting to restore voiding and bowel function in spina bifida: 3-year experience. Adv Urol. 2014;17 Article ID 863209, 7 pages. doi:10.1155/2014/863209.

Download references

Acknowledgment

I am grateful to Prof. Chris Chapple, Consultant Urological Surgeon, Sheffield Teaching Hospitals, and Honorary Professor, Sheffield Hallam University, UK, for his review of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Krishnamurthy Sairam FRCS (Urol) .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer India

About this chapter

Cite this chapter

Sairam, K. (2015). Neurogenic Bladder. In: Tamilselvi, A., Rane, A. (eds) Principles and Practice of Urogynaecology. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1692-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-1692-6_9

  • Published:

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-1691-9

  • Online ISBN: 978-81-322-1692-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Navigation